BET3L Activators
BET3L activators belong to a specialized chemical class that interacts with cellular transport mechanisms, particularly focusing on the TRAPP complex's function. BET3L, a central player within this complex, is involved in the tethering step that is essential for the proper fusion of transport vesicles to their target membranes. Activators targeting BET3L work by modulating the protein-protein interactions and processes that are essential for vesicular trafficking. They exert influence by either affecting cellular signaling pathways that regulate the TRAPP complex or by directly modifying the complex's operations. By doing so, these chemicals can alter vesicle dynamics, ensuring accurate delivery of cellular components to their intended destinations within the cell, an essential feature for maintaining cellular homeostasis.
The modes of action for BET3L activators are diverse, impacting various cellular processes. These chemicals can stimulate or inhibit pathways that control the activity of the TRAPP complex, leading to changes in protein phosphorylation patterns, cytoskeletal organization, and the regulation of molecular switches such as GTPases. Such modifications can have sweeping effects on the cell, triggering a series of responses that enhance the functionality of the TRAPP complex. Activators of BET3L, therefore, are not just mere influencers of a single protein but are pivotal in orchestrating a broader spectrum of cellular activities. Their role is crucial in enabling the cell to adjust its vesicle trafficking efficiency and adapt to the fluctuating demands of intracellular transport and signaling, with BET3L serving as a vital regulatory hub within this complex network of cellular dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts ER-to-Golgi transport by inhibiting the formation of COPI and COPII vesicles. Its presence could upregulate compensatory mechanisms that could enhance TRAPPC3L expression or TRAPP complex activity to restore trafficking pathways. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin acts as an ionophore that disrupts Golgi function by altering pH and ion gradients. Its use could induce stress responses that could enhance the activity of trafficking complexes as a compensatory mechanism. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubules, potentially altering vesicle transport dynamics. In response to such disruption, cells could upregulate trafficking proteins, including components of the TRAPP complex, to maintain transport processes. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium ions can inhibit GSK-3β, a kinase that may have roles in phosphorylation states of proteins involved in trafficking. Inhibition of GSK-3β could lead to changes in trafficking dynamics and could enhance TRAPP complex activity as part of the cellular response. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
ML-141 is a potent and selective inhibitor of Cdc42, a small GTPase involved in actin filament organization and vesicle trafficking. Inhibition of Cdc42 could affect trafficking pathways, which could lead to alterations in TRAPP complex function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that could affect various signaling pathways, including those related to vesicle trafficking. By altering the phosphorylation state of proteins, genistein could influence the function of the TRAPP complex. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a GTPase inhibitor that blocks dynamin's function, a protein involved in vesicle scission from membranes. This inhibition could affect vesicle trafficking and could potentially influence the activity of the TRAPP complex. | ||||||
DBeQ | 177355-84-9 | sc-499943 | 10 mg | $330.00 | 1 | |
DBeQ is a selective ATPase inhibitor of the AAA-type p97 ATPase. It can interfere with the segregation of protein complexes from membranes, thereby impacting vesicle trafficking and could influence TRAPP complex function. | ||||||